Home › Cancro del polmone non a piccole cellule › Ohio › Akron
Studi clinici su Cancro del polmone non a piccole cellule a Akron, OH
22 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi a Akron e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
In reclutamentoFase 3
- Cleveland Clinic Akron General, Akron
- Aultman Health Foundation, Canton · a 21 mi di distanza
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
In reclutamentoFase 3
- Aultman Health Foundation, Canton · a 21 mi di distanza
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
In reclutamentoFase 3
- Akron General Medical Center, Akron
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
In reclutamentoFase 3
- Aultman North, North Canton · a 15 mi di distanza
- Aultman Massillon, Massillon · a 20 mi di distanza
- Aultman Orrville Hospital, Orrville · a 21 mi di distanza
- e altri 2
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
In reclutamentoFase 3
- Research Site, Canton · a 21 mi di distanza
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
In reclutamentoFase 3
- Aultman Hospital, Canton · a 21 mi di distanza
Pan-tumor MRD Study
In reclutamentoStudio osservazionale
- Gabrail Cancer Center, Canton · a 21 mi di distanza
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
In reclutamentoFase 2/3
- Gabrail Cancer Center Research, Canton · a 21 mi di distanza
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
In reclutamentoFase 2
- Gabrail Cancer Center, Canton · a 21 mi di distanza
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
In reclutamentoFase 2/3
- Tricounty Hematology and Oncology - Massillon, Massillon · a 20 mi di distanza
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
In reclutamentoFase 1/2
- Gabrail Cancer Center Research, Canton · a 21 mi di distanza
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
In reclutamentoFase 3
- Gabrail Cancer Center, Canton · a 21 mi di distanza
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
In reclutamentoFase 2
- Gabrail Cancer and Research Center, Canton · a 21 mi di distanza
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Cleveland Clinic Mercy Hospital, Canton · a 21 mi di distanza
- Aultman Health Foundation, Canton · a 21 mi di distanza
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Aultman Health Foundation, Canton · a 21 mi di distanza
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Aultman Health Foundation, Canton · a 21 mi di distanza
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2/3
- Aultman Health Foundation, Canton · a 21 mi di distanza
GEMINI-NSCLC: NSCLC Biomarker Study
In reclutamentoStudio osservazionale
- Aultman Hospital, Canton · a 21 mi di distanza
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
In reclutamentoFase 1
- Gabrail Cancer & Research Center, Canton · a 21 mi di distanza
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
In reclutamentoFase 1/2
- Research Site 138, Canton · a 21 mi di distanza
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
In reclutamentoFase 1/2
- Gabrail Cancer Center Research, Canton · a 21 mi di distanza
FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
In reclutamentoFase 1/2
- Gabrail Cancer Research Center, Canton · a 21 mi di distanza
Studi su Cancro del polmone non a piccole cellule in altre città
- Houston, TX145 studi
- New York City, NY120 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH56 studi
- Washington, DC55 studi
Altri studi a Akron
- Cancro ai polmoni16 studi
- Cancro (tutti i tipi)13 studi
- Cancro al seno13 studi
- Cancro alla prostata9 studi
- Leucemia mieloide acuta8 studi
- Melanoma8 studi
- Carcinoma polmonare a piccole cellule8 studi
- Cancro metastatico8 studi
- Cancro colorettale8 studi
- Malattia epatica steatosica7 studi
- Cancro dell'endometrio6 studi
- Cancro ovarico6 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.